Fred Alger Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $298K | Buy |
|
|||||
|
2025
Q2 | $253K | Sell |
|
|||||
|
2025
Q1 | $252K | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $967K | Sell |
|
|||||
|
2023
Q3 | $10.1M | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $17.8K | Sell |
|
|||||
|
2022
Q4 | $24.7M | Buy |
|
|||||
|
2022
Q3 | $24K | Hold |
|
|||||
|
2022
Q2 | $22K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $673K | Sell |
|
|||||
|
2019
Q4 | $4.12M | Buy |
|
|||||
|
2019
Q3 | $2.55M | Buy |
|
|||||
|
2019
Q2 | $2.03M | Sell |
|
|||||
|
2019
Q1 | $3.66M | Sell |
|
|||||
|
2018
Q4 | $3.27M | Sell |
|
|||||
|
2018
Q3 | $7.41M | Sell |
|
|||||
|
2018
Q2 | $6.04M | Buy |
|
|||||
|
2018
Q1 | $3.83M | Buy |
|
|||||
|
2017
Q4 | $2.93M | Buy |
|
|||||
|
2017
Q3 | $357K | Buy |
|
|||||
|
2017
Q2 | $18K | Sell |
|
|||||
|
2017
Q1 | $753K | Sell |
|
|||||
|
2016
Q4 | $1.93M | Buy |
|
|||||
|
2016
Q3 | $2.23M | Buy |
|
|||||
|
2016
Q2 | $1.73M | Sell |
|
|||||
|
2016
Q1 | $3.55M | Sell |
|
|||||
|
2015
Q4 | $9.13M | Sell |
|
|||||
|
2015
Q3 | $6.99M | Sell |
|
|||||
|
2015
Q2 | $13.7M | Sell |
|
|||||
|
2015
Q1 | $15.5M | Sell |
|
|||||
|
2014
Q4 | $14M | Buy |
|
|||||
|
2014
Q3 | $9.34M | Buy |
|
|||||
|
2013
Q4 | – | Sell |
|
|||||
|
2013
Q3 | $17K | Buy |
|